DAM
CLBR

DLD Asset Management’s Colombier Acquisition Corp III CLBR Stock Holding History

DLD Asset Management’s Portfolio CLBR Stock Details CLBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.1M Buy
+400,000
New +$4.06M 0.27% 51

Other funds holding CLBR

DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

DLD Asset Management's CLBR Position: Q2 2026 in Review

DLD Asset Management opened a new position in Colombier Acquisition Corp III (CLBR) in Q2 2026: 400,000 shares worth $4.1M. The stake represents 0.27% of the portfolio and ranks #51 among its holdings.

56 funds tracked by Wall St. Rank hold CLBR as of Q2 2026.

  • DLD Asset Management held 400,000 shares of Colombier Acquisition Corp III worth $4.1M as of Q2 2026.
  • Colombier Acquisition Corp III was a new DLD Asset Management position in Q2 2026.
  • Colombier Acquisition Corp III made up 0.27% of DLD Asset Management's portfolio in Q2 2026, its #51 holding.
  • 56 funds tracked by Wall St. Rank held Colombier Acquisition Corp III as of Q2 2026.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.